From theheart.org on Medscape

Coverage from the

The Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions

April 25 - 28, 2018; San Diego, California

April 25 - 28, 2018 San Diego, California

Conference News

Popular News from SCAI 2017

  • BRAVO 3 TAVR and AF: Stroke Risk, Discharge Meds Differ BRAVO 3 TAVR and AF: Stroke Risk, Discharge Meds Differ In the BRAVO-3 trial of patients who had transfemoral TAVR with procedural bivalirudin or heparin, patients with new-onset AF had a much greater stroke risk; there was also an "incredible" variation in discharge meds.
  • Radial, Femoral Robotic PCI Success in Multisite PRECISION Study Radial, Femoral Robotic PCI Success in Multisite PRECISION Study After correction for baseline differences, 'clinical success, technical success, patient radiation exposure, and PCI procedure times were comparable to either radial or femoral access for robotic PCI.'
  • 30-Day Readmissions Reduced at High-Volume TAVR Centers 30-Day Readmissions Reduced at High-Volume TAVR Centers All TAVR centers should strive to be top performers, experts say, although the observational study doesn't explain causes of the difference. Readmissions at high-volume centers were also less costly/

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage